| Net Cash Provided by (Used in) Operating Activities |
$14,624 |
USD |
36% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$17,950 |
USD |
-20% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q2 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
2,868,000 |
shares |
0% |
Q2 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$121 |
USD |
|
Q1 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$884 |
USD |
1303% |
Q2 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$77,464 |
USD |
35% |
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Gross |
$77,464 |
USD |
35% |
Q4 2024 |
FY 2025 |
| Depreciation |
$146 |
USD |
2.1% |
Q1 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$85,740 |
USD |
56% |
Q2 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$340,638 |
USD |
36% |
Q4 2024 |
FY 2025 |
| Additional Paid in Capital |
$35,839 |
USD |
0% |
Q2 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2025 |
| Interest Expense |
$7,710 |
USD |
112% |
Q2 2025 |
Q2 2026 |